LifeStance Health Group LFST
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
LifeStance Health Group (LFST) Business Model and Operations Summary
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Key Insights
LifeStance Health Group (LFST) Core Market Data and Business Metrics
Latest Closing Price
$6.63Market Cap
$2.56 BillionTotal Outstanding Shares
384.55 Million SharesTotal Employees
10,218Dividend
No dividendIPO Date
June 10, 2021SIC Description
Services-health ServicesPrimary Exchange
NASDAQHeadquarters
4800 N. Scottsdale Road, Scottsdale, AZ, 85251
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-9.95 Million |
| Net Cash Flow From Financing Activities, Continuing | $-9.95 Million |
| Net Cash Flow, Continuing | $75.75 Million |
| Net Cash Flow From Investing Activities, Continuing | $-21.57 Million |
| Net Cash Flow | $75.75 Million |
| Net Cash Flow From Operating Activities, Continuing | $107.26 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Depreciation and Amortization | $70.95 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Nonoperating Income/Loss | $-26 Million |
| Operating Expenses | $1.28 Billion |
| Operating Income/Loss | $-31.61 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-58.82 Million |
| Other Comprehensive Income/Loss | $-1.37 Million |
| Comprehensive Income/Loss Attributable To Parent | $-58.82 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Liabilities | $443.13 Million |
| Liabilities And Equity | $2.12 Billion |
| Liabilities | $672.01 Million |
| Wages | $117.46 Million |
| Current Liabilities | $228.89 Million |
| Assets | $2.12 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||